Dr. Reddys Buy Or Sell?
Know what 36 Analysts are recommending?
- Markets
- MasterclassNEW
- Portfolio X-ray
- StockIQNEW
- My Watchlist
- News
- Stock Recos
- Screeners
- AI Chart PatternsNEW
- ETMarkets GPT
US Stocks
- Sector: Pharmaceuticals
- Industry: Pharma - Indian
Dr. Reddys - Dr. Reddy's Laboratories Share Price
1,374.005.71 (0.42%)
Volume: 18,28,860
LiveLast Updated On: 04 Nov, 2026, 03:51 PM IST
- Open:1,360.00
- High:1,376.70
- Low:1,359.80
Loading...
Research insights
Key Metrics
PE RatioThis is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. | 40.96 | ||||||||||
EPS - TTMEarnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. | 33.54 | ||||||||||
MCapMCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. | 1,14,685.07 | ||||||||||
Sectoral MCap RankThis is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned. | 6 | ||||||||||
PB RatioPrice to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. | 2.99 | ||||||||||
Dividend YieldDividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors. | 0.58 | ||||||||||
Face ValueFace value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value. | 1.00 | ||||||||||
Beta
| 0.75 | ||||||||||
VWAPVolume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. | 1,367.84 | ||||||||||
52W H/LThis represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. | 1,414.90 / 1,101.00 |
Dr. Reddys Share Price Insights
- Company has spent 1.11% of its operating revenues towards interest expenses and 17.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Dr. Reddy's Laboratories Ltd. share price moved up by 0.42% from its previous close of Rs 1,368.30. Dr. Reddy's Laboratories Ltd. stock last traded price is 1,374.00
Share Price Value Today/Current/Last 1,374.00 Previous Day 1,368.30
Dr. Reddys Share Price Returns
| 1 Day | 0.42% |
| 1 Week | 2.16% |
| 1 Month | 14.21% |
| 3 Months | 16.84% |
| 1 Year | 14.5% |
| 3 Years | 30.53% |
| 5 Years | 44.14% |
ET Stock ScreenersTop Score Companies
Check whether Dr. Reddys belongs to analysts' top-rated companies list?
View Stock ScreenersNews & Analysis
Share Recommendations
Recent Recos
Current
Mean Recos by 36 Analysts
BUY
Strong SellSellHoldBuyStrong Buy
Analyst Trends
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 9 | 9 | 6 | 5 |
| Buy | 12 | 12 | 8 | 9 |
| Hold | 8 | 8 | 9 | 10 |
| Sell | 7 | 7 | 11 | 10 |
| Strong Sell | - | - | 2 | 4 |
| # Analysts | 36 | 36 | 36 | 38 |
Financials
Insights
| | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Total Income | 8,854.00 | 8,454.50 | 8,021.80 | 9,022.20 | 9,152.20 |
| Total Income Growth (%) | 4.73 | 5.39 | -11.09 | -1.42 | 3.27 |
| Total Expenses | 7,493.90 | 7,776.50 | 7,721.00 | 7,386.90 | 7,323.00 |
| Total Expenses Growth (%) | -3.63 | 0.72 | 4.52 | 0.87 | 6.52 |
| EBIT | 1,360.10 | 678.00 | 300.80 | 1,635.30 | 1,829.20 |
| EBIT Growth (%) | 100.60 | 125.40 | -81.61 | -10.60 | -7.98 |
| Profit after Tax (PAT) | 924.80 | 444.30 | 220.90 | 1,209.90 | 1,347.10 |
| PAT Growth (%) | 108.15 | 101.13 | -81.74 | -10.18 | -5.01 |
| EBIT Margin (%) | 15.36 | 8.02 | 3.75 | 18.13 | 19.99 |
| Net Profit Margin (%) | 10.44 | 5.26 | 2.75 | 13.41 | 14.72 |
| Basic EPS () | 11.10 | 5.33 | 2.65 | 14.53 | 16.18 |
All figures in Rs Cr, unless mentioned otherwise
View DetailsShare Price Forecast
Get multiple analysts' prediction on Dr. Reddys
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
Technicals
Peer Comparison
MF Ownership
1,782.68
Amount Invested (in Cr.)
1.22883572%
% of AUM
1.11
% Change (MoM basis)
1,179.91
Amount Invested (in Cr.)
2.06097257%
% of AUM
2.38
% Change (MoM basis)
ICICI Pru India Opportunities Direct-G
Equity: Thematic-Other967.25
Amount Invested (in Cr.)
2.65225062%
% of AUM
0.00
% Change (MoM basis)
Dr. Reddys F&O Quote
- Expiry
Price
1,243.8011.80 (0.96%)
Open Interest
27,23,7504,90,000 (21.94%)
| Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
|---|---|---|---|---|---|
| 1,238.00 | 1,246.10 | 1,233.00 | 1,232.00 | 1,128 | 8,735.83 |
Open Interest as of 4 Nov 2026
Corporate Actions
| Meeting Date | Announced on | Purpose | Details |
|---|---|---|---|
| Oct 23, 2026 | Sep 22, 2026 | Board Meeting | Quarterly Results |
| Jul 23, 2026 | Jun 30, 2026 | AGM | General Meeting |
| Jul 22, 2026 | Jun 22, 2026 | Board Meeting | Quarterly Results |
| May 12, 2026 | Mar 23, 2026 | Board Meeting | Audited Results |
| Jan 21, 2026 | Dec 23, 2025 | Board Meeting | Quarterly Results |
| Oct 24, 2025 | Sep 22, 2025 | Board Meeting | Quarterly Results |
| Jul 24, 2025 | May 9, 2025 | AGM | General Meeting |
| Sep 14, 2024 | Aug 16, 2024 | POM | General Meeting |
| Jul 29, 2024 | May 7, 2024 | AGM | Book closure from Jul 17, 2024 to Jul 19, 2024 |
| Feb 15, 2024 | Jan 15, 2024 | POM | General Meeting |
About Dr. Reddys
Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 1,14,685.07 Crore) operating in Pharmaceuticals sector.
Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Service Income, Spent Chemicals, Scrap and Other Operating Revenue for the year ending 31-Mar-2026.
GP
G V Prasad
Co-Chairman & Manag. DirectorKR
K Satish Reddy
ChairmanEI
Erez Israeli
Chief Executive OfficerMR
M V Ramana
CEO - Global GenericsDS
Deepak Sapra
CEO - API & ServicesMK
Milan Kalawadia
CEO - North AmericaIndustry
Key Indices Listed On
Nifty 50, Nifty 100, Nifty 200, + 46 more
Address
8-2-337, Road No.3,, Banjara Hills,, Hyderabad, Telangana, 500034
More Details
- Dr. Reddy's Laboratories Ltd. Chairman's Speech
- Dr. Reddy's Laboratories Ltd. Company History
- Dr. Reddy's Laboratories Ltd. Directors Report
- Dr. Reddy's Laboratories Ltd. Background information
- Dr. Reddy's Laboratories Ltd. Company Management
- Dr. Reddy's Laboratories Ltd. Listing Information
- Dr. Reddy's Laboratories Ltd. Finished Products
Brands
Dr. Reddy's Laboratories
FAQs about Dr. Reddys share
- 1. What is Dr. Reddys share price and what are the returns for Dr. Reddys share?Dr. Reddys share price is Rs 1,374.00 as on 04 Nov, 2026, 03:51 PM IST. Dr. Reddys share price is up by 0.42% based on previous share price of Rs. 1368.3.
- 2. What is 52 week high/low of Dr. Reddys share price?52 Week high of Dr. Reddys share is Rs 1,414.90 while 52 week low is Rs 1,101.00
- 3. What is the PE & PB ratio of Dr. Reddys?The PE ratio of Dr. Reddys stands at 40.96, while the PB ratio is 3.0.
- 4. What are the returns for Dr. Reddys share?Return Performance of Dr. Reddys Shares: 1 Week: Dr. Reddys share price moved up by 2.16%
- 5. What's the market capitalization of Dr. Reddys?Market Capitalization of Dr. Reddys stock is Rs 114,685 Cr.
Trending in Markets
Top Gainers
Top Losers
Dr. Reddys Quick Links
Equity Quick Links
More from Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
